Persistence of thyroid hormones disorders in chronic heart failure out patients: “Heart hypothyroidism”

Persistence of thyroid hormones disorders in chronic heart failure out patients: “Heart hypothyroidism”

dasdasdasdasd

Although progress in understanding heart failure (HF) has been considerable in recent decades, mortality rates remain high, and estimated increases in HF-related morbidity and mortality suggest that our understanding of the pathophysiological mechanisms of this syndrome is inadequate. Thyroid hormones (THs) regulate cardiac performance by acting on the heart and vascular system, and maintenance of THs homeostasis is required for proper cardiovascular function [ 1 , 2 ].

References
1. Biondi B.
Heart failure and thyroid dysfunction.
Eur J Endocrinol. 2012; 167: 609-618
2. Gerdes A. - Iervasi G.
Thyroid replacement therapy and heart failure.
Circulation. 2010; 122 : 385-393
3. Singh S., Duggal J., Molnar J., Maldonado F., Barsano C., Arora R.
Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis.
Int J Cardiol. 2008; 125: 41-48
4. Iacoviello M., Guida P., Gustamachia E., et al.
Prognostic role of subclinical hypothyroidism in chronic heart failure outpatients.
Curr Pharm Des. 2008; 14: 2686-2692
5. Pingitore A., Landi P., Taddei M.C., Ripoli A., L'Abbate A., Iervasi G.
Triiodothyronine levels for risk stratification of patients with chronic heart failure.
Am J Med. 2005; 118: 132-136
6. Brenta G., Thierer J., Sutton M., et al.
Low plasma triiodothyronine levels in heart failure are associated with a reduced anabolic state and membrane damage.
Eur J Endocrinol. 2011; 164: 937-942
7. Silva-Tinoco R., Castillo-Martinez L., Orea-Tejeda A., et al.
Developing thyroid disorders is associated with poor prognosis factors in patients with stable chronic heart failure.
Int J Cardiol. 2011; 147: e24-e25
8. Colín-Ramírez E., Castillo-Ramírez L., Orea-Tejeda A., Vázquez-Durán M., Rodríguez A.E., Keirns-Davis C.
Bioelectrical impedance phase angle as prognostic marker in chronic heart failure.
Nutrition. 2012;
https://doi.org/10.1016/j.nut.2011.11.033
9. Jin H., Fedorowicz G., Yang R., et al.
Thyrotropin-releasing hormone is induced in the left ventricular of rats with heart failure and can provide inotropic support to the failing heart.
Circulation. 2004; 109: 2240-2245
10. Coats A.J.
Ethical authorship and publishing.
Int J Cardiol. 2009; 131: 149-150

Referencia: https://www.internationaljournalofcardiology.com/article/S0167-5273(12)01541-0/fulltext

Comentarios